[1] |
Bray F, Ferlay J, Soerjomataram I , et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018,68(6):394-424. DOI: 10.3322/caac.21492.
|
[2] |
Chen W, Zheng R, Baade PD , et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016,66(2):115-132. DOI: 10.3322/caac.21338.
|
[3] |
Maresso KC, Tsai KY, Brown PH , et al. Molecular cancer prevention: current status and future directions[J]. CA Cancer J Clin, 2015,65(5):345-383. DOI: 10.3322/caac.21287.
|
[4] |
Kumar G, Mittal S, Sak K , et al. Molecular mechanisms underlying chemopreventive potential of curcumin: current challenges and future perspectives[J]. Life Sci, 2016,148:313-328. DOI: 10.1016/j.lfs.2016.02.022.
|
[5] |
杨芳, 刘少琼, 李春花 , 等. 姜黄素下调结直肠癌细胞Notch1信号通路研究[J]. 湖南中医药大学学报, 2015, 35(4): 10-13, 50, 封3. DOI: 10.3969/j.issn.1674-070X.2015.04.003.
|
[6] |
Sankpal UT, Nagaraju GP, Gottipolu SR , et al. Combination of tolfenamic acid and curcumin induces colon cancer cell growth inhibition through modulating specific transcription factors and reactive oxygen species[J]. Oncotarget, 2016,7(3):3186-3200. DOI: 10.18632/oncotarget.6553.
|
[7] |
Radhakrishnan VM, Kojs P, Young G , et al. pTyr421 cortactin is overexpressed in colon cancer and is dephosphorylated by curcumin: involvement of non-receptor type 1 protein tyrosine phosphatase (PTPN1)[J]. PLoS One, 2014,9(1):e85796. DOI: 10.1371/journal.pone.0085796.
|
[8] |
Zhang L, Cheng X, Gao Y , et al. Curcumin inhibits metastasis in human papillary thyroid carcinoma BCPAP cells via down-regulation of the TGF-β/Smad2/3 signaling pathway[J]. Exp Cell Res, 2016,341(2):157-165. DOI: 10.1016/j.yexcr.2016.01.006.
|
[9] |
陈贵娥, 唐源, 刘满英 , 等. 苹果多糖抑制人结肠癌细胞SW-620转移的作用及机制研究[J]. 现代肿瘤医学, 2019,27(12):2040-2044.
|
[10] |
张典, 王粉侠, 弥曼 , 等. 苹果多糖预防小鼠结肠炎癌变的作用及其机制研究[J]. 中国药学杂志, 2015,50(17):1527-1531. DOI: 10.11669/cpj.2015.17.015.
|
[11] |
Liu Y, Zhao J, Zhao Y , et al. Therapeutic effects of lentinan on inflammatory bowel disease and colitis-associated cancer[J]. J Cell Mol Med, 2019,23(2):750-760. DOI: 10.1111/jcmm.13897.
|
[12] |
Suga Y, Takehana K . Lentinan diminishes apoptotic bodies in the ileal crypts associated with S-1 administration[J]. Int Immunopharmacol, 2017,50:55-60. DOI: 10.1016/j.intimp.2017.06.012.
|
[13] |
Wang J, Li W, Huang X , et al. A polysaccharide from Lentinus edodes inhibits human colon cancer cell proliferation and suppresses tumor growth in athymic nude mice[J]. Oncotarget, 2017,8(1):610-623. DOI: 10.18632/oncotarget.13481.
|
[14] |
Li Y, Sun Y, Fan L , et al. Paris saponin Ⅶ inhibits growth of colorectal cancer cells through Ras signaling pathway[J]. Biochem Pharmacol, 2014,88(2):150-157. DOI: 10.1016/j.bcp.2014.01.018.
|
[15] |
Zhou H, Sun Y, Zheng H , et al. Paris saponin Ⅶ extracted from trillium tschonoskii suppresses proliferation and induces apoptosis of human colorectal cancer cells[J]. J Ethnopharmacol, 2019,239:111903. DOI: 10.1016/j.jep.2019.111903.
|
[16] |
Chen M, Ye K, Zhang B , et al. Paris saponin Ⅱ inhibits colorectal carcinogenesis by regulating mitochondrial fission and NF-κB pathway[J]. Pharmacol Res, 2019,139:273-285. DOI: 10.1016/j.phrs.2018.11.029.
|
[17] |
于思 . 重楼皂苷Ⅰ诱导ROS蓄积介导结肠癌细胞周期阻滞和自噬的研究[D]. 成都: 成都中医药大学, 2018.
|
[18] |
Han S, Jeong AJ, Yang H , et al. Ginsenoside 20(S)-Rh2 exerts anti-cancer activity through targeting IL-6-induced JAK2/STAT3 pathway in human colorectal cancer cells[J]. J Ethnopharmacol, 2016,194:83-90. DOI: 10.1016/j.jep.2016.08.039.
|
[19] |
Wang J, Chen Y, Dai C , et al. Ginsenoside Rh2 alleviates tumor-associated depression in a mouse model of colorectal carcinoma[J]. Am J Transl Res, 2016,8(5):2189-2195.
|
[20] |
Tang YC, Zhang Y, Zhou J , et al. Ginsenoside Rg3 targets cancer stem cells and tumor angiogenesis to inhibit colorectal cancer progre-ssion in vivo[J]. Int J Oncol, 2018,52(1):127-138. DOI: 10.3892/ijo.2017.4183.
|
[21] |
Yang X, Zou J, Cai H , et al. Ginsenoside Rg3 inhibits colorectal tumor growth via down-regulation of C/EBPβ/NF-κB signaling[J]. Biomed Pharmacother, 2017, 1240-1245. DOI: 10.1016/j.biopha.2017.11.092.
|
[22] |
Qiu R, Qian F, Wang X , et al. Targeted delivery of 20(S)-ginse-noside Rg3-based polypeptide nanoparticles to treat colon cancer[J]. Biomed Microdevices, 2019,21(1):18. DOI: 10.1007/s10544-019-0374-0.
|
[23] |
Phi LTH, Wijaya YT, Sari IN , et al. The anti-metastatic effect of ginsenoside Rb2 in colorectal cancer in an EGFR/SOX2-dependent manner[J]. Cancer Med, 2018,7(11):5621-5631. DOI: 10.1002/cam4.1800.
|
[24] |
Chen H, Jin ZL, Xu H . MEK/ERK signaling pathway in apoptosis of SW620 cell line and inhibition effect of resveratrol[J]. Asian Pac J Trop Med, 2016,9(1):49-53. DOI: 10.1016/j.apjtm.2015.12.010.
|
[25] |
Du Z, Zhou F, Jia Z , et al. The hedgehog/Gli-1 signaling pathways is involved in the inhibitory effect of resveratrol on human colorectal cancer HCT116 cells[J]. Iran J Basic Med Sci, 2016,19(11):1171-1176.
|
[26] |
Demoulin B, Hermant M, Castrogiovanni C , et al. Resveratrol induces DNA damage in colon cancer cells by poisoning topoisomerase Ⅱ and activates the ATM kinase to trigger p53-dependent apoptosis[J]. Toxicol In Vitro, 2015,29(5):1156-1165. DOI: 10.1016/j.tiv.2015.04.015.
|
[27] |
Nana AW, Wu SY, Yang YS , et al. Nano-diamino-tetrac (NDAT) enhances resveratrol-induced antiproliferation by action on the RRM2 pathway in colorectal cancers[J]. Horm Cancer, 2018,9(5):349-360. DOI: 10.1007/s12672-018-0334-9.
|
[28] |
Karimi Dermani F, Saidijam M, Amini R , et al. Resveratrol inhibits proliferation, invasion, and epithelial-mesenchymal transition by increasing miR-200c expression in HCT-116 colorectal cancer cells[J]. J Cell Biochem, 2017,118(6):1547-1555. DOI: 10.1002/jcb.25816.
|
[29] |
Darband SG, Kaviani M, Yousefi B , et al. Quercetin: a functional dietary flavonoid with potential chemo-preventive properties in colo-rectal cancer[J]. J Cell Physiol, 2018,233(9):6544-6560. DOI: 10.1002/jcp.26595.
|
[30] |
Roy S, Das R, Ghosh B , et al. Deciphering the biochemical and molecular mechanism underlying the in vitro and in vivo chemotherapeutic efficacy of ruthenium quercetin complex in colon cancer[J]. Mol Carcinog, 2018,57(6):700-721. DOI: 10.1002/mc.22792.
|
[31] |
Ahmed HH, Aglan HA, Zaazaa AM , et al. Quercetin confers tumoricidal activity through multipathway mechanisms in a N-methylnitrosourea rat model of colon cancer[J]. Asian Pac J Cancer Prev, 2016,17(11):4991-4998. DOI: 10.22034/APJCP.2016.17.11.4991.
|
[32] |
Yang Y, Wang T, Chen D , et al. Quercetin preferentially induces apoptosis in KRAS-mutant colorectal cancer cells via JNK signaling pathways[J]. Cell Biol Int, 2019,43(2):117-124. DOI: 10.1002/cbin.11055.
|
[33] |
Zhang Z, Li B, Xu P , et al. Integrated whole transcriptome profiling and bioinformatics analysis for revealing regulatory pathways associ-ated with quercetin-induced apoptosis in HCT-116 cells[J]. Front Pharmacol, 2019,10:798. DOI: 10.3389/fphar.2019.00798.
|
[34] |
Langner E, Lemieszek MK, Rzeski W . Lycopene, sulforaphane, quercetin, and curcumin applied together show improved antiprolife-rative potential in colon cancer cells in vitro[J]. J Food Biochem, 2019,43(4):e12802. DOI: 10.1111/jfbc.12802.
|